|
US2065593A
(en)
|
|
1936-12-29 |
|
Water-soluble diazoimino com |
|
FR472489A
(fr)
|
1914-02-20 |
1914-12-08 |
Stas Motor Ges M B H |
Bague de garniture métallique pour pistons
|
|
US2065900A
(en)
|
1935-03-23 |
1936-12-29 |
Gen Aniline Works Inc |
Dihydroxystilbene-dicarboxylic acid and a process of preparing it
|
|
US2071329A
(en)
|
1935-08-22 |
1937-02-23 |
Solvay Process Co |
Method of recovering phthalic anhydride
|
|
GB728767A
(en)
|
1951-10-12 |
1955-04-27 |
Wander Ag Dr A |
2-substituted chromone compounds, and a method of making same
|
|
US3251837A
(en)
|
1962-09-14 |
1966-05-17 |
Pfizer & Co C |
Derivatives of 1, 2, 4-benzothiadiazine-1, 1-dioxides
|
|
GB1179019A
(en)
|
1967-05-23 |
1970-01-28 |
Produits Chimique Soc Et |
Polynicotinic Esters of Flavonoids
|
|
FR6928M
(https=)
|
1967-11-24 |
1969-05-05 |
|
|
|
US3600394A
(en)
|
1968-05-17 |
1971-08-17 |
Searle & Co |
2-aminoalkyl-3-arylisocarbostyrils
|
|
US3930024A
(en)
|
1969-09-02 |
1975-12-30 |
Parke Davis & Co |
Pharmaceutical compositions and methods
|
|
US3773946A
(en)
|
1969-09-02 |
1973-11-20 |
Parke Davis & Co |
Triglyceride-lowering compositions and methods
|
|
FR2244493A1
(en)
|
1973-08-09 |
1975-04-18 |
Pluripharm |
Flavonoid amino-acid salts - for treatment of haemorrhage, circulatory disorders and atherosclerosis
|
|
DE2349024A1
(de)
|
1973-09-26 |
1975-04-10 |
Schering Ag |
6beta,7beta-epoxy-1alpha,2alphamethylen-d-homo-4-pregnen-3,20-dione
|
|
IT1050750B
(it)
|
1975-12-05 |
1981-03-20 |
Erba Carlo Spa |
Derivati della 3.4 di idro chinazolina
|
|
US4159330A
(en)
|
1976-11-02 |
1979-06-26 |
Carlo Erba S.P.A. |
2-Disubstituted phenyl-3,4-dihydro-4-oxo-quinazoline derivatives and process for their preparation
|
|
US5098903A
(en)
|
1980-03-07 |
1992-03-24 |
Board Of Regents Of The University Of Oklahoma |
Diphenylcyclopropyl analogs as antiestrogenic and antitumor agents
|
|
IL64542A0
(en)
|
1981-12-15 |
1982-03-31 |
Yissum Res Dev Co |
Long-chain alpha,omega-dicarboxylic acids and derivatives thereof and pharmaceutical compositions containing them
|
|
JPS60136512A
(ja)
|
1983-12-26 |
1985-07-20 |
Eisai Co Ltd |
脂質代謝改善剤
|
|
DE3423166A1
(de)
|
1984-06-22 |
1986-01-02 |
Epis S.A., Zug |
Alpha-, omega-dicarbonsaeuren, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten
|
|
EP0182213B1
(en)
|
1984-11-08 |
1990-09-26 |
Sumitomo Pharmaceuticals Company, Limited |
Carbapenem compounds and production thereof
|
|
DE3515882A1
(de)
|
1985-05-03 |
1986-11-06 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
Arzneimittel, enthaltend pyridinone mit antithrombotischen wirkungen und verfahren zu ihrer herstellung
|
|
DE3532279A1
(de)
|
1985-09-11 |
1987-03-12 |
Bayer Ag |
1,4-benzoxathiin-derivate
|
|
DE3601417A1
(de)
|
1986-01-20 |
1987-07-23 |
Nattermann A & Cie |
2'-alkyl-(alkenyl-) substituierte quercetine
|
|
EP0258190B1
(de)
|
1986-08-29 |
1991-11-27 |
Ciba-Geigy Ag |
Verfahren zur Herstellung von aromatischen Ether- und Thioetherverbindungen
|
|
EP0272455B1
(en)
|
1986-11-24 |
1993-02-10 |
Fujisawa Pharmaceutical Co., Ltd. |
3-Pyrrolidinylthio-1-azabicyclo [3.2.0] hept-2-ene-2-carboxylic acid compounds
|
|
GB8804058D0
(en)
|
1988-02-22 |
1988-03-23 |
Fujisawa Pharmaceutical Co |
3-alkenyl-1-azabicyclo(3 2 0)hept-2-ene-2-carboxylic acid compounds
|
|
US4925838A
(en)
|
1988-03-18 |
1990-05-15 |
Fujisawa Pharmaceutical Company, Ltd. |
3-pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid compounds
|
|
US4963544A
(en)
|
1988-05-23 |
1990-10-16 |
Fujisawa Pharmaceutical Company, Ltd. |
3-pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid compounds
|
|
GB8926981D0
(en)
|
1988-12-23 |
1990-01-17 |
Ici Plc |
Heterocyclic derivatives
|
|
IE902465A1
(en)
|
1989-07-07 |
1991-02-13 |
Schering Corp |
Pharmaceutically active compounds
|
|
FR2649612A1
(fr)
|
1989-07-17 |
1991-01-18 |
Rhone Poulenc Sante |
Medicaments a base de derives de 1h-benzoxadiazine-4,1,2 nouveaux derives et leurs procedes de preparation
|
|
IE64358B1
(en)
|
1989-07-18 |
1995-07-26 |
Ici Plc |
Diaryl ether heterocycles
|
|
GB9018134D0
(en)
|
1989-09-29 |
1990-10-03 |
Ici Plc |
Heterocyclic derivatives
|
|
JP3180344B2
(ja)
|
1990-06-05 |
2001-06-25 |
東レ株式会社 |
インドール誘導体
|
|
JP2999579B2
(ja)
|
1990-07-18 |
2000-01-17 |
武田薬品工業株式会社 |
Ｄｎａおよびその用途
|
|
GB9025832D0
(en)
|
1990-11-28 |
1991-01-09 |
Ashwell Geoffrey J |
Novel films for nonlinear optical applications
|
|
IE913866A1
(en)
|
1990-11-28 |
1992-06-03 |
Ici Plc |
Aryl derivatives
|
|
US5126351A
(en)
|
1991-01-24 |
1992-06-30 |
Glaxo Inc. |
Antitumor compounds
|
|
MX9200299A
(es)
|
1991-02-07 |
1992-12-01 |
Roussel Uclaf |
Nuevos derivados biciclicos nitrogenados, su procedimiento de preparacion los nuevos compuestos intermedios obtenidos su aplicacion como medicamentos y las composiciones farmaceuticas que los contienen.
|
|
AU1746392A
(en)
|
1991-04-10 |
1992-11-17 |
Octamer, Inc. |
A method for inhibition of retroviral replication
|
|
US5409930A
(en)
|
1991-05-10 |
1995-04-25 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
|
|
US5480883A
(en)
|
1991-05-10 |
1996-01-02 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
|
|
US5124337A
(en)
|
1991-05-20 |
1992-06-23 |
Schering Corporation |
N-acyl-tetrahydroisoquinolines as inhibitors of acyl-coenzyme a:cholesterol acyl transferase
|
|
US5223506A
(en)
|
1991-06-04 |
1993-06-29 |
Glaxo Inc. |
Cyclic antitumor compounds
|
|
PT100905A
(pt)
|
1991-09-30 |
1994-02-28 |
Eisai Co Ltd |
Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
|
|
US5250679A
(en)
|
1991-10-18 |
1993-10-05 |
Genentech, Inc. |
Nonpeptidyl platelet aggregation inhibitors having specificity for the GPIIb III.sub. receptor
|
|
GB9126260D0
(en)
|
1991-12-11 |
1992-02-12 |
Pfizer Ltd |
Therapeutic agents
|
|
US5474994A
(en)
|
1992-05-26 |
1995-12-12 |
Recordati S.A., Chemical And Pharmaceutical Company |
Bicyclic heterocyclic derivatives having α1 -adrenergic and 5HT1A
|
|
FR2689127B1
(fr)
|
1992-03-31 |
1994-05-06 |
Adir Cie |
Nouvelles 3', 5' -ditertbutyl-4'-hydroxy flavones, leur procede de preparation et les compositions pharmaceutiques les renfermant.
|
|
US7655699B1
(en)
|
1992-04-22 |
2010-02-02 |
Eisai Inc. |
Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
|
|
DE4215587A1
(de)
|
1992-05-12 |
1993-11-18 |
Bayer Ag |
Sulfonylbenzyl-substituierte Benzo- und Pyridopyridone
|
|
DE4215588A1
(de)
|
1992-05-12 |
1993-11-18 |
Bayer Ag |
Biphenylmethyl-substituierte Pyridone
|
|
GB9218334D0
(en)
|
1992-08-28 |
1992-10-14 |
Ici Plc |
Heterocyclic compounds
|
|
JPH0680656A
(ja)
|
1992-09-03 |
1994-03-22 |
Mitsui Petrochem Ind Ltd |
光学活性エポキシドの製造方法
|
|
AU5850894A
(en)
|
1992-12-23 |
1994-07-19 |
Procept, Inc. |
Novel agents for inhibition of hiv infectivity and use therefor
|
|
JPH0741442A
(ja)
|
1993-05-21 |
1995-02-10 |
Sumitomo Chem Co Ltd |
アセチレンアルコール誘導体およびその製造法
|
|
JPH0761942A
(ja)
|
1993-06-17 |
1995-03-07 |
Sumitomo Chem Co Ltd |
フェノール誘導体およびその製造法
|
|
JPH0725761A
(ja)
|
1993-07-09 |
1995-01-27 |
Kureha Chem Ind Co Ltd |
軟骨保護剤
|
|
EP0709373B1
(en)
|
1993-07-23 |
2001-10-17 |
Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai |
Pyrrolidine derivative
|
|
US5707547A
(en)
|
1993-08-03 |
1998-01-13 |
Sumitomo Chemical Company, Limited |
Trans-olefin compounds, method for production thereof, liquid crystal composition containing the same as active ingredient, and liquid crystal element using said composition
|
|
JPH07118241A
(ja)
|
1993-09-01 |
1995-05-09 |
Sumitomo Chem Co Ltd |
フェノール誘導体およびその製造法
|
|
JPH07179380A
(ja)
|
1993-12-22 |
1995-07-18 |
Sumitomo Chem Co Ltd |
アルコール誘導体およびその製造法
|
|
JPH07233109A
(ja)
|
1994-02-24 |
1995-09-05 |
Sumitomo Chem Co Ltd |
光学活性なアルコール誘導体およびその製造法
|
|
AU680736B2
(en)
|
1994-02-25 |
1997-08-07 |
Banyu Pharmaceutical Co., Ltd. |
Carbapenem derivative
|
|
US5798344A
(en)
|
1994-03-08 |
1998-08-25 |
Otsuka Pharmaceutical Factory, Inc. |
Phosphonic ester derivatives of quinazolinones
|
|
JPH07247289A
(ja)
|
1994-03-11 |
1995-09-26 |
Mitsui Petrochem Ind Ltd |
クロメンオキシド類の製造方法
|
|
FR2718329B1
(fr)
|
1994-03-21 |
2002-09-20 |
Rhone Poulenc Rorer Sa |
Lapin transgénique sensibilisé aux dyslipoprotéinémies.
|
|
US6048903A
(en)
|
1994-05-03 |
2000-04-11 |
Robert Toppo |
Treatment for blood cholesterol with trans-resveratrol
|
|
US6168776B1
(en)
|
1994-07-19 |
2001-01-02 |
University Of Pittsburgh |
Alkyl, alkenyl and alkynyl Chrysamine G derivatives for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
|
|
GB2292149A
(en)
|
1994-08-09 |
1996-02-14 |
Ferring Res Ltd |
Peptide inhibitors of pro-interleukin-1beta converting enzyme
|
|
JP3702493B2
(ja)
|
1994-08-12 |
2005-10-05 |
大正製薬株式会社 |
キナゾリン−４（３ｈ）−オン誘導体
|
|
HUT76853A
(en)
|
1994-11-14 |
1997-12-29 |
Warner Lambert Co |
6-aryl pyrido[2,3-d]pyrimidines and naphthyridines for inhibiting protein tyrosine kinase mediated cellular proliferation and pharmaceutical compositions containing the same
|
|
IL115256A0
(en)
|
1994-11-14 |
1995-12-31 |
Warner Lambert Co |
6-Aryl pyrido (2,3-d) pyrimidines and naphthyridines and their use
|
|
US5446071A
(en)
|
1994-11-18 |
1995-08-29 |
Eli Lilly And Company |
Methods for lowering serum cholesterol
|
|
JP4140981B2
(ja)
|
1994-12-26 |
2008-08-27 |
東菱薬品工業株式会社 |
再狭窄症及び動脈硬化症治療薬
|
|
US5648387A
(en)
|
1995-03-24 |
1997-07-15 |
Warner-Lambert Company |
Carboxyalkylethers, formulations, and treatment of vascular diseases
|
|
WO1996031206A2
(en)
|
1995-04-07 |
1996-10-10 |
Warner-Lambert Company |
Flavones and coumarins as agents for the treatment of atherosclerosis
|
|
ES2180702T3
(es)
|
1995-06-07 |
2003-02-16 |
Lilly Co Eli |
Tratamiento de patologias por la induccion del factor de transcripcion bef-1.
|
|
CN1090621C
(zh)
|
1995-08-30 |
2002-09-11 |
株式会社大冢制药厂 |
制备喹唑啉－4－酮衍生物的方法
|
|
AU4858596A
(en)
|
1995-09-15 |
1997-04-01 |
Torrey Pines Institute For Molecular Studies |
Synthesis of quinazolinone libraries
|
|
US5783577A
(en)
|
1995-09-15 |
1998-07-21 |
Trega Biosciences, Inc. |
Synthesis of quinazolinone libraries and derivatives thereof
|
|
KR19990067010A
(ko)
|
1995-10-23 |
1999-08-16 |
오스테오스크린, 인코포레이티드 |
골결핍 상태의 치료용 조성물 및 그 치료방법
|
|
HU224225B1
(hu)
|
1995-12-01 |
2005-06-28 |
Sankyo Co. Ltd. |
Tachikinin receptor antagonista hatású heterociklusos vegyületek, ezek előállítási eljárása és alkalmazásuk gyógyszerkészítmények előállítására
|
|
US5756736A
(en)
|
1996-01-26 |
1998-05-26 |
Syntex (U.S.A.) Inc. |
Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
|
|
WO1997028118A1
(en)
|
1996-02-05 |
1997-08-07 |
Hoechst Celanese Corporation |
Process for preparing anthranilic acids
|
|
US5763608A
(en)
|
1996-02-05 |
1998-06-09 |
Hoechst Celanese Corporation |
Process for preparing pyrimidine derivatives
|
|
US5739330A
(en)
|
1996-02-05 |
1998-04-14 |
Hoechst Celanese Corporation |
Process for preparing quinazolones
|
|
ES2161442T3
(es)
|
1996-02-12 |
2001-12-01 |
Univ Rutgers |
Analogos de coralina como inhibidores de topoisomerasa.
|
|
HUP9904567A3
(en)
|
1996-06-20 |
2001-10-29 |
Univ Texas |
Use of azo, thioalkyl, thiocarbonyl derivatives substituted by fused heterocycles and/or phenyl group for the preparation of pharmaceutical compositions stimulating bone growth
|
|
US5854264A
(en)
|
1996-07-24 |
1998-12-29 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
KR100213895B1
(ko)
|
1996-10-14 |
1999-08-02 |
박원훈 |
감귤류 과피 추출물, 이로부터 분리 정제된 헤스페리딘 또는 나린진을 포함하는 심혈관 질환 예방및 치료제 조성물
|
|
DE19651099A1
(de)
|
1996-12-09 |
1998-06-10 |
Consortium Elektrochem Ind |
Mehrkomponentensystem zum Verändern, Abbau oder Bleichen von Lignin, ligninhaltigen Materialien oder ähnlichen Stoffen sowie Verfahren zu seiner Anwendung
|
|
IL119971A
(en)
|
1997-01-07 |
2003-02-12 |
Yissum Res Dev Co |
Pharmaceutical compositions containing dicarboxylic acids and derivatives thereof and some novel dicarboxylic acids
|
|
JPH10287678A
(ja)
|
1997-04-11 |
1998-10-27 |
Kyowa Hakko Kogyo Co Ltd |
ピラノアジン誘導体
|
|
AR012634A1
(es)
|
1997-05-02 |
2000-11-08 |
Sugen Inc |
Compuesto basado en quinazolina, composicion famaceutica que lo comprende, metodo para sintetizarlo, su uso, metodos de modulacion de la funcion deserina/treonina proteinaquinasa con dicho compuesto y metodo in vitro para identificar compuestos que modulan dicha funcion
|
|
AU745790B2
(en)
|
1997-05-13 |
2002-03-28 |
Octamer, Inc. |
Methods for treating inflammation and inflammatory diseases using pADPRT inhibitors
|
|
US5908861A
(en)
|
1997-05-13 |
1999-06-01 |
Octamer, Inc. |
Methods for treating inflammation and inflammatory disease using pADPRT inhibitors
|
|
CN100525766C
(zh)
|
1997-06-02 |
2009-08-12 |
詹森药业有限公司 |
用作平滑肌细胞增殖抑制剂的（咪唑-5-基）甲基-2-喹啉酮衍生物
|
|
IL121165A0
(en)
|
1997-06-26 |
1997-11-20 |
Yissum Res Dev Co |
Pharmaceutical compositions containing carboxylic acids and derivatives thereof
|
|
TW450964B
(en)
|
1997-08-29 |
2001-08-21 |
Takeda Schering Plough Animal |
Triazine derivatives, their production and use
|
|
US20020022636A1
(en)
|
1997-09-03 |
2002-02-21 |
Jia-He Li |
Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity
|
|
US6635642B1
(en)
|
1997-09-03 |
2003-10-21 |
Guilford Pharmaceuticals Inc. |
PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same
|
|
US6239114B1
(en)
|
1997-09-26 |
2001-05-29 |
Kgk Synergize |
Compositions and methods for treatment of neoplastic diseases with combinations of limonoids, flavonoids and tocotrienols
|
|
ATE404539T1
(de)
|
1997-10-02 |
2008-08-15 |
Eisai R&D Man Co Ltd |
Kondensierte pyridinderivate
|
|
CN1124134C
(zh)
|
1997-10-28 |
2003-10-15 |
韩国科学技术研究院 |
柚苷和柚苷配基作为肝病的预防或治疗剂的应用
|
|
GB9725782D0
(en)
|
1997-12-05 |
1998-02-04 |
Pfizer Ltd |
Therapeutic agents
|
|
DE19756388A1
(de)
|
1997-12-18 |
1999-06-24 |
Hoechst Marion Roussel De Gmbh |
Substituierte 2-Aryl-4-amino-chinazoline
|
|
JP2002500039A
(ja)
|
1998-01-08 |
2002-01-08 |
アベンティス ファーマスーティカルズ プロダクツ インコーポレイテッド |
機能あるヒトリポタンパク質（ａ）を発現するトランスジェニックウサギ
|
|
US6414037B1
(en)
|
1998-01-09 |
2002-07-02 |
Pharmascience |
Pharmaceutical formulations of resveratrol and methods of use thereof
|
|
DK1074268T3
(da)
|
1998-03-17 |
2008-04-28 |
Chugai Pharmaceutical Co Ltd |
IL-6-receptorantagonistantistofholdige forebyggende eller terapeutiske midler mod inflammatoriske tarmsygdomme
|
|
US6022901A
(en)
|
1998-05-13 |
2000-02-08 |
Pharmascience Inc. |
Administration of resveratrol to prevent or treat restenosis following coronary intervention
|
|
ATE350060T1
(de)
|
1998-08-24 |
2007-01-15 |
Chugai Pharmaceutical Co Ltd |
Mittel zur vorbeugung oder behandlung von pankreatitis die anti-il-6 receptor antikörper als aktive komponente enthalten
|
|
SE9802973D0
(sv)
|
1998-09-03 |
1998-09-03 |
Astra Ab |
Immediate release tablet
|
|
KR20010079922A
(ko)
|
1998-09-24 |
2001-08-22 |
미우라 아키라 |
하이드록시플라본 유도체
|
|
WO2000023075A1
(fr)
|
1998-10-19 |
2000-04-27 |
Eisai Co., Ltd. |
Analgesiques
|
|
CN1327384A
(zh)
|
1998-10-20 |
2001-12-19 |
韩国科学技术研究院 |
作为血浆高密度脂蛋白浓度增高剂的生物类黄酮
|
|
AU2190700A
(en)
|
1998-12-17 |
2000-07-03 |
Tularik Inc. |
Tubulin-binding agents
|
|
US6291456B1
(en)
|
1998-12-30 |
2001-09-18 |
Signal Pharmaceuticals, Inc. |
Compounds and methods for modulation of estrogen receptors
|
|
US6399633B1
(en)
|
1999-02-01 |
2002-06-04 |
Aventis Pharmaceuticals Inc. |
Use of 4-H-1-benzopryan-4-one derivatives as inhibitors of smooth muscle cell proliferation
|
|
NZ513206A
(en)
|
1999-03-15 |
2004-02-27 |
Abbott Lab |
6-O-substituted macrolides having antibacterial activity
|
|
US6969720B2
(en)
|
1999-03-17 |
2005-11-29 |
Amr Technology, Inc. |
Biaryl substituted purine derivatives as potent antiproliferative agents
|
|
US6054435A
(en)
|
1999-03-19 |
2000-04-25 |
Abbott Laboratories |
6-O-substituted macrolides having antibacterial activity
|
|
NZ515086A
(en)
|
1999-04-28 |
2003-10-31 |
Aventis Pharma Gmbh |
Di-aryl acid derivatives as PPAR receptor ligands
|
|
US6835755B1
(en)
|
1999-06-24 |
2004-12-28 |
University Of Pretoria |
Naphthoquinone derivatives and their use in the treatment and control of tuberculosis
|
|
DE19934799B4
(de)
|
1999-07-28 |
2008-01-24 |
Az Electronic Materials (Germany) Gmbh |
Chiral-smektische Flüssigkristallmischung und ihre Verwendung in Aktivmatrix-Displays mit hohen Kontrastwerten
|
|
JP2001131151A
(ja)
|
1999-11-02 |
2001-05-15 |
Shionogi & Co Ltd |
オレフィン誘導体の新規用途
|
|
JP5278983B2
(ja)
|
1999-11-17 |
2013-09-04 |
塩野義製薬株式会社 |
アミド化合物の新規用途
|
|
DE60043120D1
(de)
|
1999-12-06 |
2009-11-19 |
Welichem Biotech Inc |
Polyhydroxystilbene und -stilbenoxide als antipsoriasismittel und proteinkinasehemmer
|
|
FR2804679B1
(fr)
|
2000-02-07 |
2002-04-26 |
Clariant France Sa |
Nouveaux composes phenoliques derives des dialcoxyethanals, leur procede de preparation et leur application
|
|
EP1183224B1
(en)
|
2000-02-17 |
2004-08-04 |
Appleton Papers Inc. |
Process for preparing alkoxy or arylmethoxy aroxyethanes
|
|
CN1186324C
(zh)
|
2000-04-27 |
2005-01-26 |
山之内制药株式会社 |
稠合杂芳基衍生物
|
|
WO2001082916A2
(en)
|
2000-05-03 |
2001-11-08 |
Tularik Inc. |
Combination therapeutic compositions and methods of use
|
|
US6548694B2
(en)
|
2000-05-23 |
2003-04-15 |
Hoffman-La Roche Inc. |
N-(4-carbamimidoyl-phenyl)-glycine derivatives
|
|
JP2001335476A
(ja)
|
2000-05-29 |
2001-12-04 |
Shionogi & Co Ltd |
三環化合物の新規用途
|
|
US6479499B1
(en)
|
2000-06-28 |
2002-11-12 |
National Science Council |
2-phenyl-4-quinazolinone compounds, 2-phenyl-4-alkoxy-quinazoline compounds and their pharmaceutical compositions
|
|
US20020025301A1
(en)
|
2000-07-04 |
2002-02-28 |
Sylke Haremza |
Novel flavonoids and their use in cosmetic and dermatological preparations
|
|
US6541522B2
(en)
|
2000-08-16 |
2003-04-01 |
Insmed Incorporated |
Methods of using compositions containing hypotriglyceridemically active stilbenoids
|
|
US7723303B2
(en)
|
2000-08-24 |
2010-05-25 |
The Regents Of The University Of California |
Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response
|
|
JP2004510767A
(ja)
|
2000-10-02 |
2004-04-08 |
モレキュラー・プロウブズ・インコーポレーテッド |
アルデヒド部分またはケトン部分を有する生物分子を標識するための試薬
|
|
CA2356544C
(en)
|
2000-10-03 |
2006-04-04 |
Warner-Lambert Company |
Pyridotriazines and pyridopyridazines
|
|
PL362546A1
(en)
|
2000-10-05 |
2004-11-02 |
Fujisawa Pharmaceutical Co, Ltd. |
Benzamide compounds as apo b secretion inhibitors
|
|
AU2002211666A1
(en)
|
2000-10-11 |
2002-04-22 |
Esperion Therapeutics, Inc. |
Sulfide and disulfide compounds and compositions for cholesterol management and related uses
|
|
MXPA03003024A
(es)
|
2000-10-11 |
2003-07-14 |
Esperion Therapeutics Inc |
Compuestos de sulfoxido y bis-sulfoxido y composiciones para el control de colesterol y usos relacionados.
|
|
IL154984A0
(en)
|
2000-10-19 |
2003-10-31 |
Merck & Co Inc |
Estrogen receptor modulators
|
|
CN1285601C
(zh)
|
2000-11-30 |
2006-11-22 |
佳能株式会社 |
发光器件和显示器
|
|
IL156315A0
(en)
|
2000-12-07 |
2004-01-04 |
Cv Therapeutics Inc |
Abca-1 elevating compounds
|
|
KR100472694B1
(ko)
|
2000-12-30 |
2005-03-07 |
한국생명공학연구원 |
플라바논 유도체 및 이를 포함하는 혈중 지질 농도 관련질환의 예방 및 치료용 조성물
|
|
JP2002249483A
(ja)
|
2001-02-21 |
2002-09-06 |
Koei Chem Co Ltd |
アリール置換複素環式化合物の製造法
|
|
WO2002074307A1
(en)
|
2001-03-16 |
2002-09-26 |
Novogen Research Pty Ltd |
Treatment of restenosis
|
|
WO2002087556A2
(en)
|
2001-04-11 |
2002-11-07 |
Atherogenics, Inc. |
Probucol monoesters and their use to increase plasma hdl cholesterol levels and improve hdl functionality
|
|
US6890915B2
(en)
|
2001-05-25 |
2005-05-10 |
Bristol-Myers Squibb Pharma Company |
Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)
|
|
US20030211086A1
(en)
*
|
2001-06-05 |
2003-11-13 |
Neil Berkley |
Minicell-based selective absorption
|
|
WO2003007959A1
(en)
|
2001-07-16 |
2003-01-30 |
Fujisawa Pharmaceutical Co., Ltd. |
Quinoxaline derivatives which have parp inhibitory action
|
|
GB0118752D0
(en)
|
2001-08-01 |
2001-09-26 |
Pfizer Ltd |
Process for the production of quinazolines
|
|
JP2005504047A
(ja)
|
2001-08-13 |
2005-02-10 |
チバ スペシャルティ ケミカルズ ホールディング インコーポレーテッド |
紫外線吸収剤
|
|
US20040248950A1
(en)
|
2001-08-24 |
2004-12-09 |
Natsuki Ishizuka |
Apo ai expression accelerating agent
|
|
US20040235877A1
(en)
|
2001-09-14 |
2004-11-25 |
Natsuki Ishizuka |
Novel use of tricyclic compound
|
|
US7429593B2
(en)
|
2001-09-14 |
2008-09-30 |
Shionogi & Co., Ltd. |
Utilities of amide compounds
|
|
US8124625B2
(en)
|
2001-09-14 |
2012-02-28 |
Shionogi & Co., Ltd. |
Method of enhancing the expression of apolipoprotein AI using olefin derivatives
|
|
US6835469B2
(en)
|
2001-10-17 |
2004-12-28 |
The University Of Southern California |
Phosphorescent compounds and devices comprising the same
|
|
US7166368B2
(en)
|
2001-11-07 |
2007-01-23 |
E. I. Du Pont De Nemours And Company |
Electroluminescent platinum compounds and devices made with such compounds
|
|
US7250512B2
(en)
|
2001-11-07 |
2007-07-31 |
E. I. Du Pont De Nemours And Company |
Electroluminescent iridium compounds having red-orange or red emission and devices made with such compounds
|
|
US6541045B1
(en)
|
2002-01-04 |
2003-04-01 |
Nutraceutical Corporation |
Herbal composition and method for combating inflammation
|
|
WO2003064399A1
(fr)
|
2002-01-28 |
2003-08-07 |
Ube Industries, Ltd. |
Procede de production de derive de quinazolin-4-one
|
|
US20040127492A1
(en)
|
2002-02-19 |
2004-07-01 |
Pharmacia Corporation |
Cyclic pyrazoles for the inhibition of mitogen activated protein kinase-activated protein kinase-2
|
|
GB0206033D0
(en)
|
2002-03-14 |
2002-04-24 |
Pfizer Ltd |
Compounds useful in therapy
|
|
NZ556545A
(en)
|
2002-03-22 |
2009-03-31 |
Novartis Ag |
Combination comprising a beta-hydroxy-beta-methylglutaryl-co-enzyme-A reductase inhibitor and a glucagon-like peptide-1 agonist
|
|
MY140680A
(en)
|
2002-05-20 |
2010-01-15 |
Bristol Myers Squibb Co |
Hepatitis c virus inhibitors
|
|
AU2003238157A1
(en)
|
2002-06-18 |
2003-12-31 |
Sankyo Company, Limited |
Fused-ring pyrimidin-4(3h)-one derivatives, processes for the preparation and uses thereof
|
|
KR20040001144A
(ko)
|
2002-06-27 |
2004-01-07 |
김대경 |
신규한 적혈구 세포질형 포스포리파아제 에이 투 효소,그에 대한 항체, 이들의 용도 및 제조 방법
|
|
US20050080021A1
(en)
|
2002-08-15 |
2005-04-14 |
Joseph Tucker |
Nitric oxide donating derivatives of stilbenes, polyphenols and flavonoids for the treatment of cardiovascular disorders
|
|
US20050080024A1
(en)
|
2002-08-15 |
2005-04-14 |
Joseph Tucker |
Nitric oxide donating derivatives for the treatment of cardiovascular disorders
|
|
US20040033480A1
(en)
|
2002-08-15 |
2004-02-19 |
Wong Norman C.W. |
Use of resveratrol to regulate expression of apolipoprotein A1
|
|
US20040087590A1
(en)
|
2002-08-23 |
2004-05-06 |
University Of Connecticut |
Novel biphenyl and biphenyl-like cannabinoids
|
|
AU2003262946A1
(en)
|
2002-08-30 |
2004-03-19 |
Pharmacia And Upjohn Company |
Method of preventing or treating atherosclerosis or restenosis
|
|
EP1398032A1
(en)
|
2002-09-10 |
2004-03-17 |
PheneX Pharmaceuticals AG |
4-Oxo-quinazolines as LXR nuclear receptor binding compounds
|
|
EP1407774A1
(en)
|
2002-09-10 |
2004-04-14 |
LION Bioscience AG |
2-Amino-4-quinazolinones as LXR nuclear receptor binding compounds
|
|
WO2004032846A2
(en)
|
2002-10-07 |
2004-04-22 |
Bristol-Myers Squibb Company |
Triazolone and triazolethione derivatives
|
|
US20040132732A1
(en)
|
2002-10-21 |
2004-07-08 |
Wei Han |
Quinazolinones and derivatives thereof as factor Xa inhibitors
|
|
WO2004039795A2
(en)
|
2002-10-29 |
2004-05-13 |
Fujisawa Pharmaceutical Co., Ltd. |
Amide compounds for the treatment of hyperlipidemia
|
|
CA2502302A1
(en)
|
2002-11-04 |
2004-05-21 |
Nps Pharmaceuticals, Inc. |
Quinazolinone compounds as calcilytics
|
|
EP1418164A1
(en)
|
2002-11-07 |
2004-05-12 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
New stilbene derivatives and their use as aryl hydrocarbon receptor ligand antagonists
|
|
BR0316375A
(pt)
|
2002-11-18 |
2005-10-04 |
Hoffmann La Roche |
Diazinopirimidinas
|
|
KR100772297B1
(ko)
|
2002-11-22 |
2007-11-02 |
니뽄 다바코 산교 가부시키가이샤 |
융합 비시클릭 질소-함유 헤테로사이클
|
|
ES2270154T3
(es)
|
2002-12-13 |
2007-04-01 |
F. Hoffmann-La Roche Ag |
Derivados de 3h-quinazolin-4-ona.
|
|
ITRM20020629A1
(it)
|
2002-12-19 |
2004-06-20 |
Sigma Tau Ind Farmaceuti |
Uso di acidi alfa-feniltiocarbossilici e alfa-fenilossicarbossilici ad attivita' ipoglicemizzante e/o ipolipidemizzante.
|
|
ATE496893T1
(de)
|
2002-12-20 |
2011-02-15 |
X Ceptor Therapeutics Inc |
Isochinolinonderivate und deren verwendung als medikamente
|
|
JP2004203751A
(ja)
|
2002-12-24 |
2004-07-22 |
Pfizer Inc |
置換６，６−ヘテロ二環式誘導体
|
|
CA2512000C
(en)
|
2002-12-26 |
2011-08-09 |
Eisai Co., Ltd. |
Selective estrogen receptor modulator
|
|
WO2004065392A1
(en)
|
2003-01-24 |
2004-08-05 |
Smithkline Beecham Corporation |
Condensed pyridines and pyrimidines and their use as alk-5 receptor ligands
|
|
WO2004072042A2
(en)
|
2003-02-12 |
2004-08-26 |
Carex S.A. |
Quinoline derivative and their use for modulation of lxr activity
|
|
WO2004092154A1
(en)
|
2003-04-03 |
2004-10-28 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of protein kinases
|
|
EP1610774A4
(en)
|
2003-04-09 |
2008-07-16 |
Exelixis Inc |
TIE-2 MODULATORS AND METHODS OF USE
|
|
JP2004307440A
(ja)
|
2003-04-10 |
2004-11-04 |
Kyorin Pharmaceut Co Ltd |
２−アミノ‐１，３‐プロパンジオール誘導体とその付加塩
|
|
ES2320771T3
(es)
|
2003-04-16 |
2009-05-28 |
Bristol-Myers Squibb Company |
Inhibidores peptidicos de isoquinolina macrociclicos del virus de la hepatitis c.
|
|
KR101205257B1
(ko)
|
2003-06-06 |
2012-11-27 |
아렉시스 악티에볼라그 |
피부 상태 또는 암 치료를 위한 ｓｃｃｅ 저해제로서의 융합된 헤테로사이클 화합물의 용도
|
|
WO2004112710A2
(en)
|
2003-06-17 |
2004-12-29 |
Millennium Pharmaceuticals, Inc. |
COMPOSITIONS AND METHODS FOR INHIBITING TGF-ß
|
|
EP1637523A4
(en)
|
2003-06-18 |
2009-01-07 |
Ube Industries |
PROCESS FOR PRODUCING A PYRIMIDIN-4-ONE COMPOUND
|
|
US20050043300A1
(en)
|
2003-08-14 |
2005-02-24 |
Pfizer Inc. |
Piperazine derivatives
|
|
CN1925862A
(zh)
|
2003-10-10 |
2007-03-07 |
雷斯弗洛吉克斯公司 |
与egr－1增强子元件有关的疾病的治疗
|
|
US20050096391A1
(en)
|
2003-10-10 |
2005-05-05 |
Per Holm |
Compositions comprising fenofibrate and rosuvastatin
|
|
AU2004286277A1
(en)
|
2003-10-28 |
2005-05-12 |
Reddy Us Therapeutics, Inc. |
Heterocyclic compounds and methods of making and using thereof
|
|
JP2007517071A
(ja)
|
2003-12-19 |
2007-06-28 |
メルク エンド カムパニー インコーポレーテッド |
有糸分裂キネシン阻害剤
|
|
US20080188527A1
(en)
|
2003-12-23 |
2008-08-07 |
Cashman John R |
Synthetic Compounds and Derivatives as Modulators of Smoking or Nicotine Ingestion and Lung Cancer
|
|
TW200536830A
(en)
|
2004-02-06 |
2005-11-16 |
Chugai Pharmaceutical Co Ltd |
1-(2H)-isoquinolone derivative
|
|
CN1960977B
(zh)
|
2004-05-31 |
2010-07-21 |
万有制药株式会社 |
喹唑啉衍生物
|
|
GB0512324D0
(en)
|
2005-06-16 |
2005-07-27 |
Novartis Ag |
Organic compounds
|
|
WO2006012577A2
(en)
|
2004-07-22 |
2006-02-02 |
Bayer Pharmaceuticals Corporation |
Quinazolinone derivatives useful for the regulation of glucose homeostasis and food intake
|
|
US20070218155A1
(en)
|
2004-08-20 |
2007-09-20 |
Kuhrts Eric H |
Methods and compositions for treating dyslipidaemia
|
|
WO2006045010A2
(en)
|
2004-10-20 |
2006-04-27 |
Resverlogix Corp. |
Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases
|
|
US20080152595A1
(en)
|
2004-11-24 |
2008-06-26 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of orally administered pharmaceutical products
|
|
JP2008526734A
(ja)
|
2004-12-31 |
2008-07-24 |
エスケー ケミカルズ カンパニー リミテッド |
糖尿及び肥満治療予防に有効なキナゾリン誘導体
|
|
CR9465A
(es)
|
2005-03-25 |
2008-06-19 |
Surface Logix Inc |
Compuestos mejorados farmacocineticamente
|
|
US20070004763A1
(en)
*
|
2005-06-10 |
2007-01-04 |
Nand Baindur |
Aminoquinoline and aminoquinazoline kinase modulators
|
|
CA2617213C
(en)
|
2005-07-29 |
2014-01-28 |
Resverlogix Corp. |
Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
|
|
AU2006307046A1
(en)
|
2005-10-27 |
2007-05-03 |
Msd K.K. |
Novel benzoxathiin derivative
|
|
EP1968968A1
(en)
|
2005-12-21 |
2008-09-17 |
PainCeptor Pharma Corp. |
Compositions and methods for modulating gated ion channels
|
|
PT1928425E
(pt)
|
2006-05-12 |
2013-04-11 |
Pharmathen Sa |
Formulação farmacêutica contendo um inibidor de hmg-coa redutase e método para a preparação deste
|
|
US20100055173A1
(en)
|
2006-10-10 |
2010-03-04 |
Adel Penhasi |
Release of statins in the intestine
|
|
US20080085911A1
(en)
|
2006-10-10 |
2008-04-10 |
Reliant Pharmaceuticals, Inc. |
Statin and omega-3 fatty acids for reduction of apo-b levels
|
|
EP2097391A1
(en)
|
2006-11-15 |
2009-09-09 |
High Point Pharmaceuticals, LLC |
2- ( 2 -hydroxyphenyl) -quinazolin-4-ones useful for treating obesity and diabetes
|
|
ATE524487T1
(de)
*
|
2007-01-11 |
2011-09-15 |
Univ Ramot |
Tau peptidmimetikum zur behandlung von neurodegenerativen erkrankungen
|
|
WO2008092231A1
(en)
|
2007-02-01 |
2008-08-07 |
Resverlogix Corp. |
Compounds for the prevention and treatment of cardiovascular diseases
|
|
ES2308916B1
(es)
|
2007-03-22 |
2009-10-29 |
Consejo Superior De Investigaciones Cientificas |
Compuesto inhibidor dual de las enzimas pde7 y/o pde4, composiciones farmaceuticas y sus aplicaciones.
|
|
EP2005941A3
(de)
|
2007-06-01 |
2009-04-01 |
Henkel AG & Co. KGaA |
Zellverjüngende Zusammensetzungen
|
|
WO2008152471A1
(en)
|
2007-06-12 |
2008-12-18 |
Coley Pharmaceutical Group, Inc. |
Quinazoline derivative useful as toll-like receptor antagonist
|
|
WO2008157575A1
(en)
|
2007-06-21 |
2008-12-24 |
Irm Llc |
Protein kinase inhibitors and methods for using thereof
|
|
WO2009084693A1
(ja)
|
2007-12-28 |
2009-07-09 |
Mitsubishi Tanabe Pharma Corporation |
抗癌剤
|
|
KR101629356B1
(ko)
|
2008-06-26 |
2016-06-13 |
리스버로직스 코퍼레이션 |
퀴나졸리논 유도체의 제조방법
|
|
JP2011529932A
(ja)
|
2008-08-05 |
2011-12-15 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
置換ナフチリジン及び医薬としてのその使用
|
|
JP2012505160A
(ja)
|
2008-10-06 |
2012-03-01 |
カロラス セラピューティクス， インク． |
炎症を処置する方法
|
|
US8569288B2
(en)
|
2008-10-30 |
2013-10-29 |
Circomed Llc |
Thienotriazolodiazepine derivatives active on apo A
|
|
US20100183598A1
(en)
|
2008-11-12 |
2010-07-22 |
Carolus Therapeutics, Inc. |
Methods of treating cardiovascular disorders
|
|
AU2010204106B2
(en)
|
2009-01-08 |
2014-05-08 |
Resverlogix Corp. |
Compounds for the prevention and treatment of cardiovascular disease
|
|
SG174252A1
(en)
|
2009-03-06 |
2011-10-28 |
Hoffmann La Roche |
Heterocyclic antiviral compounds
|
|
NZ755378A
(en)
|
2009-03-18 |
2022-07-29 |
Resverlogix Corp |
Novel quinazolinones and related compounds for use as anti-inflammatory agents
|
|
KR20190091564A
(ko)
*
|
2009-04-22 |
2019-08-06 |
리스버로직스 코퍼레이션 |
신규한 소염제
|
|
NZ624963A
(en)
|
2009-04-29 |
2016-07-29 |
Amarin Pharmaceuticals Ie Ltd |
Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
|
|
ES2353093B1
(es)
|
2009-05-20 |
2012-01-03 |
Consejo Superior De Investigaciones Científicas (Csic) |
Uso de derivados de quinazolinas y sus composiciones farmacéuticas en enfermedades neurodegenerativas.
|
|
GB201007286D0
(en)
|
2010-04-30 |
2010-06-16 |
Astex Therapeutics Ltd |
New compounds
|
|
DE102010048800A1
(de)
|
2010-10-20 |
2012-05-10 |
Merck Patent Gmbh |
Chinoxalinderivate
|
|
GB201018147D0
(en)
|
2010-10-27 |
2010-12-08 |
Glaxo Group Ltd |
Method of treatment
|
|
UA109797C2
(uk)
|
2010-11-05 |
2015-10-12 |
|
Спосіб боротьби з бур'янами, що мають стійкість до гербіцидів на основі феноксіалканових кислот, за допомогою 4-аміно-3-хлор-6-(4-хлор-2-фтор-3-метоксифеніл)піридин-2-карбонової кислоти і її солей або складних ефірів
|
|
AR084070A1
(es)
|
2010-12-02 |
2013-04-17 |
Constellation Pharmaceuticals Inc |
Inhibidores del bromodominio y usos de los mismos
|
|
EP2675445A1
(en)
|
2011-02-16 |
2013-12-25 |
Pivotal Therapeutics, Inc. |
Statin and omega 3 fatty acids (epa, dha and dpa) for use in cardiovascular diseases
|
|
EP2721031B1
(en)
|
2011-06-17 |
2016-01-20 |
Constellation Pharmaceuticals, Inc. |
Bromodomain inhibitors and uses thereof
|
|
HK1199028A1
(en)
|
2011-09-30 |
2015-06-19 |
Kineta, Inc. |
Anti-viral compounds
|
|
RU2640115C2
(ru)
|
2011-11-01 |
2017-12-26 |
Ресверлоджикс Корп. |
Фармацевтические композиции замещенных хиназолинонов
|
|
US20130281397A1
(en)
|
2012-04-19 |
2013-10-24 |
Rvx Therapeutics Inc. |
Treatment of diseases by epigenetic regulation
|
|
US20130281399A1
(en)
|
2012-04-19 |
2013-10-24 |
Rvx Therapeutics Inc. |
Treatment of diseases by epigenetic regulation
|
|
US20130281398A1
(en)
*
|
2012-04-19 |
2013-10-24 |
Rvx Therapeutics Inc. |
Treatment of diseases by epigenetic regulation
|
|
EP2864336B1
(en)
|
2012-06-06 |
2016-11-23 |
Constellation Pharmaceuticals, Inc. |
Benzo[b]isoxazoloazepine bromodomain inhibitors and uses thereof
|
|
ES2664050T3
(es)
|
2012-10-15 |
2018-04-18 |
Albemarle Corporation |
Procesos para la síntesis de la 2-amino-4,6-dimetoxibenzamida y otros compuestos de benzamida
|
|
RS56846B1
(sr)
|
2012-10-15 |
2018-04-30 |
Resverlogix Corp |
Jedinjenja korisna za sintezu jedinjenja benzamida
|
|
US9765039B2
(en)
|
2012-11-21 |
2017-09-19 |
Zenith Epigenetics Ltd. |
Biaryl derivatives as bromodomain inhibitors
|
|
US9073878B2
(en)
|
2012-11-21 |
2015-07-07 |
Zenith Epigenetics Corp. |
Cyclic amines as bromodomain inhibitors
|
|
AU2013365926B9
(en)
|
2012-12-21 |
2019-01-17 |
Zenith Epigenetics Ltd. |
Novel heterocyclic compounds as bromodomain inhibitors
|
|
CA2897448A1
(en)
|
2013-01-08 |
2014-07-17 |
Jerome Schentag |
Activation of the endogenous ileal brake hormone pathway for organ regeneration and related compositions, methods of treatment, diagnostics, and regulatory systems
|
|
AU2014223990A1
(en)
|
2013-02-28 |
2015-09-10 |
Washington University |
Methods of treatment of human cytomegalovirus infection and diseases with bromodomain inhibitors
|
|
EP2970312B1
(en)
|
2013-03-11 |
2017-11-15 |
The Regents of The University of Michigan |
Bet bromodomain inhibitors and therapeutic methods using the same
|
|
JP6464139B2
(ja)
|
2013-03-14 |
2019-02-06 |
コンバージーン・リミテッド・ライアビリティ・カンパニーＣｏｎｖｅｒｇｅｎｅ Ｌｌｃ |
ブロモドメイン含有タンパク質の阻害のための方法および組成物
|
|
EP2978859B1
(en)
|
2013-03-27 |
2018-06-27 |
F.Hoffmann-La Roche Ag |
Genetic markers for predicting responsiveness to therapy
|
|
TWI530499B
(zh)
|
2013-03-28 |
2016-04-21 |
吉李德科學股份有限公司 |
作為溴結構域（ｂｒｏｍｏｄｏｍａｉｎ）抑制劑之苯並咪唑酮衍生物類
|
|
WO2015025226A2
(en)
|
2013-08-21 |
2015-02-26 |
Resverlogix Corp. |
Compositions and therapeutic methods for accelerated plaque regression
|
|
JP2016528276A
(ja)
*
|
2013-08-21 |
2016-09-15 |
レスバーロジックス コーポレイション |
プラーク退縮を促進するための組成物及び治療法
|
|
US9814728B2
(en)
|
2013-09-20 |
2017-11-14 |
Saint Louis University |
Inhibition of DUX4 expression using bromodomain and extra-terminal domain protein inhibitors (BETi)
|
|
JP2017503833A
(ja)
|
2014-01-23 |
2017-02-02 |
エイチ リー モフィット キャンサー センター アンド リサーチ インスティテュート インコーポレイテッド |
イカリイン誘導体
|
|
RU2703192C2
(ru)
|
2014-07-30 |
2019-10-15 |
Ф. Хоффманн-Ля Рош Аг |
Генетические маркеры для прогнозирования ответа на терапию поднимающими уровень hdl или имитирующими hdl агентами
|
|
WO2016123054A2
(en)
|
2015-01-26 |
2016-08-04 |
The University Of North Carolina At Chapel Hill |
Kinase drug combinations and methods of use thereof
|
|
WO2016145294A1
(en)
|
2015-03-12 |
2016-09-15 |
The University Of Chicago |
Methods for determining prognosis for breast cancer patients
|
|
JO3789B1
(ar)
|
2015-03-13 |
2021-01-31 |
Resverlogix Corp |
التراكيب والوسائل العلاجية المعتمدة لمعالجة الامراض المتعلقة بالمتممة
|
|
CN107847763A
(zh)
|
2015-05-08 |
2018-03-27 |
哈佛学院院长等 |
靶向选择适合于用皮质抑素衍生物治疗的患者
|
|
US10702527B2
(en)
|
2015-06-12 |
2020-07-07 |
Dana-Farber Cancer Institute, Inc. |
Combination therapy of transcription inhibitors and kinase inhibitors
|
|
CN106265679A
(zh)
|
2015-06-28 |
2017-01-04 |
复旦大学 |
溴结构域蛋白抑制剂在制备抗hiv-1潜伏治疗药物中的用途
|
|
US9896663B2
(en)
|
2016-03-11 |
2018-02-20 |
Peter Maccallum Cancer Institute |
Leukaemia stem cell line, its method of production and uses thereof
|
|
CN106176753A
(zh)
|
2016-07-15 |
2016-12-07 |
南方医科大学 |
Rvx‑208作为hiv‑1潜伏感染逆转剂的应用
|
|
US10158038B1
(en)
*
|
2018-05-17 |
2018-12-18 |
Hi Llc |
Fast-gated photodetector architectures comprising dual voltage sources with a switch configuration
|